Per-Share Earnings, Actuals & Estimates Verve Therapeutics Inc. ; Current: · ; 1 month ago: · ; 3 months ago: · Stock analysis for Verve Therapeutics Inc (VERV:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Weekly Stock Data NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which. See the latest Verve Therapeutics Inc stock price (VERV:XNAS), related news, valuation, dividends and more to help you make your investing decisions. The Investor Relations website contains information about Verve Therapeutics's business for stockholders, potential investors, and financial analysts.
The current price of VERV is USD — it has increased by % in the past 24 hours. Watch Verve Therapeutics, Inc. stock price performance more closely on. Our Therapeutic Vision. Verve is taking a stepwise approach to clinical development with our single-course gene editing programs. VERV | Complete Verve Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Based on short-term price targets offered by nine analysts, the average price target for Verve Therapeutics comes to $ The forecasts range from a low of. FAQs ; Where is Verve Therapeutics' corporate headquarters? Verve is headquartered at Brookline Avenue, Boston, MA ; When was the company founded? Discover real-time Verve Therapeutics, Inc. Common Stock (VERV) stock prices, quotes, historical data, news, and Insights for informed trading and. 28 minutes ago. Research Verve Therapeutics' (Nasdaq:VERV) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Verve Therapeutics (VERV) - Develops therapies for cardiovascular disease by combining human genetic analysis and gene editing treatment. · Verve Plunges To. Real time Verve Therapeutics (VERV) stock price quote, stock graph, news & analysis. Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases.
The latest Verve Therapeutics stock prices, stock quotes, news, and VERV history to help you invest and trade smarter. Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news Verve Therapeutics, Inc. (VERV). Follow. Compare. + (+%). As of. Verve Therapeutics Inc. ; Volume, M ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. Verve was purpose-built to disrupt today's chronic care model for CVD, with a team of experts in cardiovascular medicine, genetics, gene editing, delivery. Verve Therapeutics, Inc. (futuresapp.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Verve Therapeutics, Inc. | Nasdaq. Get Verve Therapeutics Inc (VERV:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Based on 6 Wall Street analysts offering 12 month price targets for Verve Therapeutics in the last 3 months. The average price target is $ with a high. BOSTON (AP) — Verve Therapeutics Inc. VERV) on Thursday reported a loss of $ million in its second quarter. On a per-share basis, the Boston-based company.
In the same quarter last year, Verve Therapeutics's earnings per share (EPS) was -$ Verve Therapeutics is expected to release next earnings on 11/04/ 57 minutes ago. Track Verve Therapeutics Inc (VERV) Stock Price, Quote, latest community messages, chart, news and other stock related information. Verve Therapeutics Inc ; Dec, Initiated, Goldman, Sell, $13 ; Oct, Initiated, Credit Suisse, Neutral, $ VERV - Verve Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS).
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower. The stock price for Verve Therapeutics (NASDAQ: VERV) is $ and was last updated Today at August 19, at PM EDT. Verve Therapeutics (VERV) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. On average, Wall Street analysts predict that Verve Therapeutics's share price could reach $ by Aug 12, The average Verve Therapeutics stock price. Verve Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VERV. The last closing price for Verve Therapeutics was. Weekly Stock Data NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which. View the latest Verve Therapeutics Inc. (VERV) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Credit Card Bonus Points Offer | How Do You Get Audited By The Irs